Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor
Edwin N. Neumann, Tessa M. Bertozzi, Elaine Wu, et al.
Science (2024) Vol. 384, Iss. 6703
Closed Access | Times Cited: 22

Showing 22 citing articles:

In vivo base editing extends lifespan of a humanized mouse model of prion disease
Meirui An, Jessie R. Davis, Jonathan M. Levy, et al.
Nature Medicine (2025)
Open Access | Times Cited: 2
CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
Lei Wan, Ping Zhong, Pei Li, et al.
Neurobiology of Disease (2025) Vol. 206, pp. 106826-106826
Open Access | Times Cited: 1
Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi
Cell chemical biology (2024) Vol. 31, Iss. 8, pp. 1422-1446
Closed Access | Times Cited: 6
An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism
Nengsong Luo, Kunzhang Lin, Yuxiang Cai, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 303-315
Open Access
Identification of Chlorogenic Acids from Moringa oleifera Leaves as Modulators of Prion Aggregation Using Affinity Selection-Mass Spectrometry
Magali Silva de Amorim, Manuela Amaral-do-Nascimento, Vanessa Gisele Pasqualotto Severino, et al.
ACS Omega (2025)
Open Access
Prion Protein Endoproteolysis: Cleavage Sites, Mechanisms and Connections to Prion Disease
Andrew R. Castle, David Westaway
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Open Access
Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T Cells
Rosa Selenia Guerra-Resendez, Samantha LeGoff Lydon, J. Alex, et al.
ACS Synthetic Biology (2025)
Closed Access
Investigating the In Vivo Effects of Anti-Prion Protein Nanobodies on Prion Disease with AAV Vector
Jingjing Zhang, Mengfei Wang, Dan Wang, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 131-131
Open Access
Gene therapies for neurogenetic disorders
Orrin Devinsky, Jeff Coller, Rebecca C. Ahrens‐Nicklas, et al.
Trends in Molecular Medicine (2025)
Open Access
CRISPRoff epigenome editing for programmable gene silencing in human cell lines and primary T cells
Rithu Pattali, Izaiah J. Ornelas, Carolyn D. Nguyen, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2025), pp. 517-551
Closed Access
Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals
Aaron D. Besterman, M.A. Alnor, Oscar M. Ramirez, et al.
American Journal of Psychiatry (2025)
Closed Access
CRISPRoff epigenetic editing for programmable gene silencing in human cells without DNA breaks
Rithu Pattali, Izaiah J. Ornelas, Carolyn D. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
An epigenetic editor to silence genes
Madelynn N. Whittaker, Kiran Musunuru
Science (2024) Vol. 384, Iss. 6703, pp. 1407-1408
Closed Access | Times Cited: 1
CHARM and EvoETR: Precision epigenetic tools for gene silencing
Anirudh Pillai, Vasundhara Verma, Sanjeev Galande
BioEssays (2024)
Closed Access | Times Cited: 1
Epigenetic editing works like a CHARM
Kirsty Minton
Nature Reviews Genetics (2024) Vol. 25, Iss. 9, pp. 600-600
Closed Access
Epigenetic editor silences prion protein
Sarah Crunkhorn
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 660-660
Closed Access
Rapidly evolving genome and epigenome editing technologies
Ngoc Tung Tran, Renzhi Han
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2803-2806
Closed Access
CHARM Offensive: Epigenetic Engineering for Prion Disease
Tim Harris
GEN Biotechnology (2024) Vol. 3, Iss. 5, pp. 282-283
Closed Access
Preventing Prion Disease: An Interview with Sonia Vallabh
Sonia M. Vallabh, Julianna LeMieux
GEN Biotechnology (2024) Vol. 3, Iss. 5, pp. 278-281
Closed Access
High-throughput development and characterization of new functional nanobodies for gene regulation and epigenetic control in human cells
Jun Wan, Abby R. Thurm, Sage J. Allen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins
Da Xu, Swen Besselink, Gokul N. Ramadoss, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Therapeutic perspectives for prion diseases in humans and animals
Rebeca Benavente, Rodrigo Morales
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012676-e1012676
Open Access
Page 1

Scroll to top